What is the Syn-Tech Chem. & Pharm. Co., Ltd. stock price forecast?

Syn-Tech Chem. & Pharm. Co., Ltd. is currently trading at $70.60. View real-time AI analysis on Alpha Lenz.

What is Syn-Tech Chem. & Pharm. Co., Ltd. insider trading activity?

View the latest insider trading data for Syn-Tech Chem. & Pharm. Co., Ltd. on Alpha Lenz.

What is Syn-Tech Chem. & Pharm. Co., Ltd.'s P/E ratio?

Syn-Tech Chem. & Pharm. Co., Ltd.'s P/E ratio is 8.0.

Syn-Tech Chem. & Pharm. Co., Ltd.

TWSE · 1777

NT$70.60-0.30(-0.42%)

Ask about Syn-Tech Chem. & Pharm. Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Syn-Tech Chem. & Pharm. Co., Ltd. trades at a P/E of 8.0 (undervalued) with strong ROE of 16.1%. 3Y revenue CAGR of 12.1% highlights clear growth momentum.”

Ask for details →

Company Overview

Syn-Tech Chem. & Pharm. Co., Ltd. is a pharmaceutical manufacturer specializing in the research, development, and production of active pharmaceutical ingredients. Founded in 1982 and headquartered in Tainan, Taiwan, the company plays a vital role in the health technology sector by supplying key pharmaceutical compounds used in the formulation of various medications. Its product portfolio encompasses local anesthetics, cardiovascular medications, muscle relaxants, respiratory system drugs, central nervous system agents, digestive and urinary system drugs, and topical preparations. Syn-Tech Chem. & Pharm. Co., Ltd. serves both domestic and international clients, contributing to the reliability and supply of essential pharmaceuticals for healthcare providers and the broader medical industry. With a commitment to innovation and quality control, the company supports the pharmaceutical supply chain’s integrity and advances public health outcomes in the markets it serves.

Websitehttps://www.syn-tech.com.tw

SectorHealthcare

IndustryBiotechnology

Employees227

Company Statistics

FY 2024

Profile

NT$3.15BMarket Cap

NT$1.26BRevenue

0.00Shares Out

227Employees

Margins

38.72%Gross

50.45%EBITDA

27.91%Operating

38.82%Pre-Tax

31.27%Net

Valuation

8.00P/E

1.23P/B

2.50EV/Sales

4.10EV/EBITDA

7.70P/FCF

Growth (CAGR)

12.08%Rev 3Yr

5.85%Rev 5Yr

27.69%Op Inc 3Yr

11.84%Op Inc 5Yr

30.45%Net Inc 3Yr

19.79%Net Inc 5Yr

Returns

13.67%ROA

16.13%ROE

17.05%ROIC

Financial Health

NT$656.80MCash & Cash Equivalents

NT$-365.15MNet Debt

11.39%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Syn-Tech Chem. & Pharm. Co., Ltd. trades at a P/E of 8.0 (undervalued) with strong ROE of 16.1%. 3Y revenue CAGR of 12.1% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Syn-Tech Chem. & Pharm. Co., Ltd. (ticker: 1777) is a company listed on TWSE in the Healthcare sector (Biotechnology). It has approximately 227 employees. Market cap is $3.1B.

The current price is 70.6 with a P/E ratio of 8x and P/B of 1.23x.

ROE is 16.13% and operating margin is 27.91%. Annual revenue is $1.3B.